$8.43 5.6%
CDLX Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Cardlytics

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom.

Price $8.43
Target Price Sign up
Volume 571,080
Market Cap $389M
Year Range $5.77 - $20.25
Dividend Yield 0%
Revenue per Employee $440,114
Industry Marketing & Advertising

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2468M35M33M-24M-17M-0.090
Q4 '2389M105M-16M-101M-93M0.140
Q3 '2379M36M43M-24M-17M0.010
Q2 '2377M39M38M-24M-15M-0.240
Q1 '2364M34M31M14M21M-0.250

Insider Transactions View All

DeSieno Alexis filed to sell 6,898 shares at $8.
July 2 '24
Gupta Amit filed to sell 129,518 shares at $8.
July 2 '24
Lynton Nicholas Hollmeyer filed to sell 78,593 shares at $8.
July 2 '24
Temsamani Karim Saad filed to sell 385,530 shares at $8.7.
June 4 '24
SOSIN CLIFFORD filed to buy 6,464,859 shares at $9.
May 13 '24

What is the Market Cap of Cardlytics?

The Market Cap of Cardlytics is $389M.

How Many People Work at Cardlytics?

As of our latest update, Cardlytics employed approximately 710 people worldwide. However, it's important to note that Cardlytics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Cardlytics' revenue per employee?

$440,114. To calculate Cardlytics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Cardlytics?

Currently, the price of one share of Cardlytics stock is $8.43.

How can I analyze the CDLX stock price chart for investment decisions?

The CDLX stock price chart above provides a comprehensive visual representation of Cardlytics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Cardlytics shares. Our platform offers an up-to-date CDLX stock price chart, along with technical data analysis and alternative data insights.

Does CDLX offer dividends to its shareholders?

As of our latest update, Cardlytics (CDLX) does not offer dividends to its shareholders. Investors interested in Cardlytics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Cardlytics?

Some of the similar stocks of Cardlytics are Groupon, QuinStreet, Omnicom Group, Trade Desk, and Semrush.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.